U.S., Jan. 15 -- ClinicalTrials.gov registry received information related to the study (NCT07339748) titled 'A Clinical Study of ZL-85FA Tablets' on Dec. 30, 2025.
Brief Summary: An open-label, multicenter phase I/IIa clinical study evaluating the safety, tolerability, pharmacokinetics, and preliminary efficacy of ZL-85FA tablets in treating advanced solid tumors
Study Start Date: June 30, 2026
Study Type: INTERVENTIONAL
Condition:
Advanced Solid Tumor
Intervention:
DRUG: ZL-85FA tablets
ZL-85FA tablets 2.5mg, oral, once daily
DRUG: ZL-85FA tablets
ZL-85FA tablets 5mg, oral, once daily
DRUG: ZL-85FA tablets
ZL-85FA tablets 10mg, oral, once daily
DRUG: ZL-85FA tablets
ZL-85FA tablets 15mg, oral, once daily
DRUG: ZL-85FA tablet...